Clinical and Epidemiological Characteristics of Postdischarge Patients With COVID-19 in Tehran, Iran: Protocol for a Prospective Cohort Study (Tele-COVID-19 Study).

COVID-19 Iran cohort studies health care delivery medical education telemedicine

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
02 Feb 2021
Historique:
received: 08 08 2020
accepted: 05 01 2021
revised: 16 12 2020
pubmed: 21 1 2021
medline: 21 1 2021
entrez: 20 1 2021
Statut: epublish

Résumé

COVID-19 was declared a pandemic on March 11, 2020. Given that the severe shortage of hospital beds has led to early discharge and insufficient patient education on home care routines and isolation protocols, the close follow-up of patients and their immediate relatives is an integral part of transitioning from hospital care to home care for patients with COVID-19. We designed the Tele-COVID-19 prospective cohort to follow-up with COVID-19 patients in Tehran, Iran, and improve health care delivery and the recording of postdischarge patients' clinical profiles. All adult patients who were admitted to the COVID-19 wards of teaching hospitals in Tehran, Iran were eligible to participate in this cohort study. At baseline, patients were recruited from 4 major hospitals from March 9, 2020 to May 20, 2020. Telephone follow-ups, which were led by volunteer medical students, were conducted on postdischarge days 1-3, 5, 7, 10, and 14. We collected data on a range of sociodemographic, epidemiological, and clinical characteristics by using a standard questionnaire. Of the 950 patients with confirmed COVID-19 who were approached, 823 (response rate: 86.6%) consented and were enrolled into the cohort. Of the 823 participants, 449 (54.5%) were male. The mean age of participants was 50.1 years (SD 12.6 years). During the initial data collection phase, more than 5000 phone calls were made and over 577 reports of critical patients who were in need of urgent medical attention were recorded. The Tele-COVID-19 cohort will provide patients with sufficient education on home care and isolation, and medical advice on care and the proper use of drugs. In addition, by preventing unnecessary hospital returns and providing information on household SARS-CoV-2 transmission as early as possible, this cohort will help with effective disease management in resource-limited settings. DERR1-10.2196/23316.

Sections du résumé

BACKGROUND BACKGROUND
COVID-19 was declared a pandemic on March 11, 2020. Given that the severe shortage of hospital beds has led to early discharge and insufficient patient education on home care routines and isolation protocols, the close follow-up of patients and their immediate relatives is an integral part of transitioning from hospital care to home care for patients with COVID-19.
OBJECTIVE OBJECTIVE
We designed the Tele-COVID-19 prospective cohort to follow-up with COVID-19 patients in Tehran, Iran, and improve health care delivery and the recording of postdischarge patients' clinical profiles.
METHODS METHODS
All adult patients who were admitted to the COVID-19 wards of teaching hospitals in Tehran, Iran were eligible to participate in this cohort study. At baseline, patients were recruited from 4 major hospitals from March 9, 2020 to May 20, 2020. Telephone follow-ups, which were led by volunteer medical students, were conducted on postdischarge days 1-3, 5, 7, 10, and 14. We collected data on a range of sociodemographic, epidemiological, and clinical characteristics by using a standard questionnaire.
RESULTS RESULTS
Of the 950 patients with confirmed COVID-19 who were approached, 823 (response rate: 86.6%) consented and were enrolled into the cohort. Of the 823 participants, 449 (54.5%) were male. The mean age of participants was 50.1 years (SD 12.6 years). During the initial data collection phase, more than 5000 phone calls were made and over 577 reports of critical patients who were in need of urgent medical attention were recorded.
CONCLUSIONS CONCLUSIONS
The Tele-COVID-19 cohort will provide patients with sufficient education on home care and isolation, and medical advice on care and the proper use of drugs. In addition, by preventing unnecessary hospital returns and providing information on household SARS-CoV-2 transmission as early as possible, this cohort will help with effective disease management in resource-limited settings.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
DERR1-10.2196/23316.

Identifiants

pubmed: 33471777
pii: v10i2e23316
doi: 10.2196/23316
pmc: PMC7857388
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e23316

Informations de copyright

©Laya Jalilian Khave, Mohammad Vahidi, Dorsa Shirini, Ghazal Sanadgol, Farzad Ashrafi, Mehran Arab-Ahmadi, Alireza Fatemi, Minoosh Shabani Barzegar, Taha Hassanzadeh, Behandokht Rezaei, Alireza Zali, Davood Ommi, Shabnam Nohesara, Reza Jalili Khoshnood, Saeed Abdi, Ali Pirsalehi, Ehsan Masarat, Mostafa Shokoohi, Mohammad Karamouzian. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 02.02.2021.

Références

Clin Infect Dis. 2019 Aug 16;69(5):865-868
pubmed: 30721936
N Engl J Med. 2009 Dec 31;361(27):2619-27
pubmed: 20042753
Acad Med. 2021 Jan 1;96(1):e2
pubmed: 33031111
Lancet Public Health. 2020 May;5(5):e254
pubmed: 32272085
Int J Health Policy Manag. 2020 Oct 01;9(10):436-438
pubmed: 32610736
Int J Health Policy Manag. 2020 Aug 01;:
pubmed: 32772007
BMC Health Serv Res. 2016 Aug 18;16(1):403
pubmed: 27538884
JAMA Intern Med. 2018 Jun 1;178(6):745-746
pubmed: 29710200
Popul Health Manag. 2011 Feb;14(1):27-32
pubmed: 21090991
Int J Health Policy Manag. 2020 Oct 01;9(10):464-465
pubmed: 32610803
Dis Mon. 2002 Apr;48(4):239-48
pubmed: 12021756
Lancet Digit Health. 2020 Jun;2(6):e286-e287
pubmed: 32363333
Lancet. 2020 Feb 22;395(10224):e39
pubmed: 32035510
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 May 10;41(5):653-656
pubmed: 32213269
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
Lancet. 2020 Mar 28;395(10229):1035-1036
pubmed: 32199073

Auteurs

Laya Jalilian Khave (L)

Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mohammad Vahidi (M)

Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Dorsa Shirini (D)

Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Ghazal Sanadgol (G)

Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Farzad Ashrafi (F)

Functional Neurosurgery Research Center, Shohada Tajrish Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mehran Arab-Ahmadi (M)

Advanced Diagnostic and Interventional Radiology Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Alireza Fatemi (A)

Taleghani Hospital Research Development Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Minoosh Shabani Barzegar (M)

Taleghani Hospital Research Development Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Taha Hassanzadeh (T)

Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Behandokht Rezaei (B)

Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Alireza Zali (A)

Taleghani Hospital Research Development Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Davood Ommi (D)

Taleghani Hospital Research Development Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Shabnam Nohesara (S)

Mental Health Research Center, Psychosocial Health Research Institute, Iran University of Medical Sciences, Tehran, Iran.

Reza Jalili Khoshnood (R)

Taleghani Hospital Research Development Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Saeed Abdi (S)

Taleghani Hospital Research Development Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Ali Pirsalehi (A)

Taleghani Hospital Research Development Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Ehsan Masarat (E)

Kashan University of Medical Sciences and Health Services, Kashan, Iran.

Mostafa Shokoohi (M)

Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
HIV/Sexually Transmitted Infection Surveillance Research Center, and World Health Organization Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.

Mohammad Karamouzian (M)

HIV/Sexually Transmitted Infection Surveillance Research Center, and World Health Organization Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Faculty of Medicine, School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.

Classifications MeSH